Biotest's market cap is currently €1.39B. The company's EPS TTM is €1.731; its P/E ratio is 16.69; and it has a dividend yield of 0.28%. Biotest is scheduled to report earnings on March 28, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	€ 684.60M	€ 516.10M	€ 515.60M	€ 484.20M	€ 419.10M
Gross Profit	€ 280.30M	€ 124.90M	€ 80.70M	€ 130.10M	€ 128.80M
Operating Income	€ 143.50M	€ -13.00M	€ -52.10M	€ -13.20M	€ -6.50M
EBITDA	€ 179.00M	€ 28.30M	€ -17.70M	€ 16.00M	€ 39.40M
Net Income	€ 127.00M	€ -31.60M	€ -63.30M	€ -31.40M	€ -4.70M
Balance Sheet
Cash & Short-Term Investments	€ 118.50M	€ 136.60M	€ 117.50M	€ 89.20M	€ 85.70M
Total Assets	€ 1.41B	€ 1.20B	€ 1.10B	€ 1.13B	€ 1.11B
Total Debt	€ 689.80M	€ 574.30M	€ 496.30M	€ 469.10M	€ 409.60M
Net Debt	€ 581.70M	€ 457.70M	€ 391.90M	€ 397.80M	€ 348.80M
Total Liabilities	€ 912.00M	€ 831.90M	€ 723.80M	€ 689.70M	€ 631.50M
Stockholders' Equity	€ 498.90M	€ 371.10M	€ 380.40M	€ 441.60M	€ 476.90M
Cash Flow
Free Cash Flow	€ -36.10M	€ -69.80M	€ 15.70M	€ -43.70M	€ -67.70M
Operating Cash Flow	€ -2.70M	€ -40.50M	€ 33.90M	€ -16.70M	€ -33.60M
Investing Cash Flow	€ 1.30M	€ -37.00M	€ -23.40M	€ -14.60M	€ -8.00M
Financing Cash Flow	€ -6.80M	€ 89.60M	€ 22.60M	€ 42.00M	€ 40.50M

Currency in EUR

Biotest Earnings and Revenue History

Income Statement >

Biotest Debt to Assets

Balance Sheet >

Biotest Cash Flow

Cash Flow >

Biotest Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing